$CSTM

JPMorgan upgrades Constellium stock rating on earnings beat

JPMorgan upgraded Constellium (CSTM) to Overweight, raising its price target to $35.00. The move follows CSTM's Q3 earnings beat, with adjusted EBITDA of $280M, 12% above estimates. The company also raised its fiscal 2026 EBITDA guidance. CSTM's stock has declined 16% in the past three months, despite strong Q3 results and a positive outlook on demand.

Original reporting
Published Oct 29, 2026, 8:24 AM UTC
Analysis
AlphAI AI DeskAI-generated
Added to AlphAI Oct 29, 2026, 8:38 AM UTC. Informational, not investment advice.
How this was made
AlphAI summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
AlphAI market briefFinancial news
Primary signal
$CSTM
Bullish
high confidence
Mentioned
$CSTM
Relevance
7/10
AlphAI data visualization · based on investing.com
Decision brief

The 30-second read

$CSTMBullishHigh
01

Why it matters

The analyst upgrade provides a fresh, material catalyst that could move the stock in the short term.

02

Market read

The upgrade may trigger buying interest in CSTM and lift sentiment in related aerospace metal suppliers.

03

What to watch

Potential headwinds from European auto market slowdown and higher input costs could temper upside.

Relevance 7/10Novelty 8/10Timing: today

Background

Constellium reported Q3 adjusted EBITDA of $280 M, beating consensus by 12% and raised FY2026 EBITDA guidance.

Company-level read

Ticker impact

$CSTMBullishHigh confidence
Context

JPMorgan upgraded Constellium to Overweight after Q3 earnings beat and raised the price target to $35.

Expected impact

upward pressure as investors price in the higher target and guidance lift

Evidence & confidence

Analyst upgrade with a higher price target and raised EBITDA guidance is a fresh catalyst that typically drives buying interest.

Market effects

Positive for the aerospace and specialty metals sector as Constellium's beat suggests demand strength.

U.S. market may see modest uplift in industrial stocks.

Limited to investors tracking aerospace supply chains and metal producers.

Counterpoint

The upgrade may be premature if Q4 demand softens, making the stock vulnerable to a pullback.

Key entities

  • Constellium SE

    U.S.-listed aluminum products manufacturer (ticker CSTM).

  • JPMorgan

    Issued the Overweight upgrade and new price target.

Related articles

$CSTMMed

Constellium reports strong 2026 results

Constellium reported Q3 2026 revenue of $2.6B, up 22% YoY, and net income of $119M, up $31M. Shipments fell 1% to 368,000 tonnes. CEO Ingrid Joerg attributed growth to operational focus and market dynamics. Adjusted EBITDA rose to $276M, up $41M. Nine-month revenue reached $7.8B, up 26%, with net income at $463M, up $301M.

$CSTMMed

Constellium SE Q3 2026 Earnings Call Summary

Constellium SE reported record Q3 2026 earnings, driven by strong aerospace and North American automotive markets. The company raised 2026 EBITDA guidance to $1.03B-$1.06B. Management expects significant aerospace growth in 2027, supported by OEM build rates and tight market capacity. Strategic investments in recycling and new facilities are expected to provide cost advantages and meet growing demand.

$CSTMHighAI 8/10

Constellium (CSTM) Q3 2026 Earnings Call Transcript

Constellium (CSTM) reported Q3 2026 earnings, with revenue up 22% YoY to $2.6B and adjusted EBITDA up 17% to $276M. The company raised its full-year outlook, citing strong performance and favorable market dynamics. It also discussed manageable impacts from the Middle East conflict. Free cash flow was $128M, and $30M was returned to shareholders via share repurchases.

$CSTMMed

Constellium Q3 Earnings Call Highlights

Constellium (CSTM) reported Q3 free cash flow of $128M, reducing net debt to $1.7B. Adjusted EBITDA rose in Aerospace & Transportation and Packaging & Automotive, but fell in Automotive Structures & Industry. The company raised its 2026 EBITDA outlook to $1.03B-$1.06B and expects free cash flow to exceed $300M.